ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸
COMP <GO>

YDES vs TLSI // GROSS PROFIT MARGIN

YD Bio Limited (NASDAQ) VS. TriSalus Life Sciences Inc. (NASDAQ) • 15-METRIC TALLY: YDES 4 — TLSI 3
▲ GROSS PROFIT MARGIN LEADER: TLSI
gross-margins
28.10%
gross-margins
84.60%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (YDES VS. TLSI) EMERALD CELL = QUANTITATIVE EDGE
INSTITUTIONAL METRIC YDES TLSI SPREAD (A - B) ADVANTAGE DEDICATED URL
Gross Profit Margin ACTIVE 28.10% 84.60% -56.50 TLSI /gross-margins <GO>
Return on Invested Capital (ROIC) -20.00% -35.00% +15.00 YDES /roic <GO>
EV/EBITDA & P/E Valuation — — — TIE /valuation <GO>
Free Cash Flow Yield -1.93% -7.96% +6.03 YDES /fcf-yield <GO>
Operating Margin -60.00% -59.70% -0.30 TLSI /operating-margins <GO>
Net Profit Margin -60.00% -60.00% 0.00 TIE /net-margins <GO>
Revenue Growth (YoY) 16.90% 53.40% -36.50 TLSI /revenue-growth <GO>
Dividend Yield & FCF Payout Safety 0.00% 0.00% 0.00 TIE /dividend-safety <GO>
Altman Z-Score & Debt/Equity 13.44 — — TIE /balance-sheet <GO>
Piotroski F-Score Quality 4/9 4/9 0.00 TIE /piotroski-score <GO>
Options Implied Move & Put/Call Skew — — — TIE /options-implied-move <GO>
RSI-14 & 200D SMA Momentum 51.7 44.9 +6.80 YDES /rsi-technicals <GO>
10Y Yield & FRED Macro Beta — — — TIE /macro-sensitivity <GO>
Forward P/E Multiple — — — TIE /forward-pe <GO>
Enterprise Scale & Market Cap $415.8M $237.7M $178.1M YDES /market-cap <GO>
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
FISCAL YEAR YDES REV TLSI REV YDES GROSS % TLSI GROSS % YDES FCF TLSI FCF
FY 2025 $596.8K $45.2M 28.1% 84.6% -$8.0M -$18.9M
FY 2024 $510.4K $29.4M 30.4% 86.1% -$1.3M -$41.2M
FY 2023 $350.1K $18.5M — — -$55.7K -$50.6M
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
YDES // BETA —
TLSI // BETA —